These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1673167)

  • 1. Relation between HIV-1 syncytium inhibition antibodies and clinical outcome in children.
    Brenner TJ; Dahl KE; Olson B; Miller G; Andiman WA
    Lancet; 1991 Apr; 337(8748):1001-5. PubMed ID: 1673167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syncytium-inhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of human immunodeficiency virus type 1.
    Bal AK; Miller G; Viscarello R; Andiman WA
    Pediatr Infect Dis J; 1996 Apr; 15(4):315-20. PubMed ID: 8866800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus.
    Wilks D; Walker L; O'Brien J; Habeshaw J; Dalgleish A
    Immunology; 1990 Sep; 71(1):10-5. PubMed ID: 2210798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers.
    Rossi P; Moschese V; Broliden PA; Fundaró C; Quinti I; Plebani A; Giaquinto C; Tovo PA; Ljunggren K; Rosen J
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8055-8. PubMed ID: 2479014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Celada F; Düzgüneş N
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of syncytium-inducing primary isolates by sera from human immunodeficiency virus (HIV)-uninfected recipients of candidate HIV vaccines.
    Zolla-Pazner S; Xu S; Burda S; Duliege AM; Excler JL; Clements-Mann ML
    J Infect Dis; 1998 Nov; 178(5):1502-6. PubMed ID: 9780275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle.
    Genois N; Barbeau B; Olivier M; Tremblay MJ
    Clin Exp Immunol; 2001 Apr; 124(1):32-42. PubMed ID: 11359440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus infection in children: nature of immunodeficiency, clinical spectrum and management.
    Pahwa S
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S61-71. PubMed ID: 3041360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo.
    Fouchier RA; Meyaard L; Brouwer M; Hovenkamp E; Schuitemaker H
    Virology; 1996 May; 219(1):87-95. PubMed ID: 8623557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study.
    Maas JJ; Gange SJ; Schuitemaker H; Coutinho RA; van Leeuwen R; Margolick JB
    AIDS; 2000 Jun; 14(9):1155-61. PubMed ID: 10894279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.
    Broliden K; Sievers E; Tovo PA; Moschese V; Scarlatti G; Broliden PA; Fundaro C; Rossi P
    Clin Exp Immunol; 1993 Jul; 93(1):56-64. PubMed ID: 8324904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells.
    Forte SE; Byron KS; Sullivan JL; Somasundaran M
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1613-8. PubMed ID: 7888220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation.
    Berman PW; Nakamura GR
    AIDS Res Hum Retroviruses; 1994 May; 10(5):585-93. PubMed ID: 7917519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibody and clinical status of human immunodeficiency virus (HIV)-infected individuals.
    Alesi DR; Ajello F; Lupo G; Vitale F; Portera M; Spadaro F; Romano N
    J Med Virol; 1989 Jan; 27(1):7-12. PubMed ID: 2784162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV type 1 phenotype correlates with the stage of infection in vertically infected children.
    Balotta C; Viganò A; Riva C; Colombo MC; Salvaggio A; de Pasquale MP; Crupi L; Papagno L; Galli M; Moroni M; Principi N
    AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1247-53. PubMed ID: 8870846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells.
    Sekigawa I; Chamow SM; Groopman JE; Byrn RA
    J Virol; 1990 Oct; 64(10):5194-8. PubMed ID: 2398542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) and its determinants: a cohort study in Kigali, Rwanda.
    Lepage P; Van de Perre P; Msellati P; Hitimana DG; Simonon A; Van Goethem C; Mukamabano B; Karita E; Stevens AM; Mathieu G
    Am J Epidemiol; 1993 Mar; 137(6):589-99. PubMed ID: 8470660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.
    Ljunggren K; Moschese V; Broliden PA; Giaquinto C; Quinti I; Fenyö EM; Wahren B; Rossi P; Jondal M
    J Infect Dis; 1990 Feb; 161(2):198-202. PubMed ID: 2299204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals.
    Llano A; Barretina J; Gutiérrez A; Blanco J; Cabrera C; Clotet B; Esté JA
    J Virol; 2001 Nov; 75(21):10319-25. PubMed ID: 11581400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.